CN Patent

CN120865208A — Tyk2抑制剂和其用途

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2025-10-31 · 1y expired

What this patent protects

本发明提供了化合物、其组合物和将其用于抑制TYK2并治疗TYK2介导的病症的方法。

USPTO Abstract

本发明提供了化合物、其组合物和将其用于抑制TYK2并治疗TYK2介导的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120865208A
Jurisdiction
CN
Classification
—
Expires
2025-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.